Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2014
Innate immunity in cystic fibrosis lung disease.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2012
Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2011
Resistance to dermcidin-derived peptides is independent of bacterial protease activity.
International journal of antimicrobial agents·2009
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2009
Severe hypercalcemia in a patient with end-stage liver disease.
JCEM case reports·2026
UNC93B1 drives IL-6/STAT3-dependent tumor-macrophage crosstalk and epithelial-mesenchymal transition in breast cancer.
Frontiers in pharmacology·2026
Early esophageal squamous neoplasia and the microbiome: evidence, mechanisms, and early-detection potential.
Frontiers in microbiology·2026